Patch testing while immunosuppressed: potential risks and benefits

References

• Brites GS, Ferreira I, Sebastião AI, et al. Allergic contact dermatitis: from pathophysiology to development of new preventive strategies. Pharmacol Res. 2020 Dec;162:105282. doi: 10.1016/j.phrs.2020.105282
   PubMed Web of Science ®Google Scholar
• Garg V, Brod B, Gaspari AA. Patch testing: uses, systems, risks/benefits, and its role in managing the patient with contact dermatitis. Clin Dermatol. 2021;39(4):580–590. doi: 10.1016/j.clindermatol.2021.03.005
   PubMed Web of Science ®Google Scholar
• Mufti A, Lu JD, Sachdeva M, et al. Patch testing during immunosuppressive therapy: a systematic review. Dermat Contact Atopic Occup Drug. 2021 Dec 1;32(6):365–374. doi: 10.1097/DER.0000000000000726
   PubMed Web of Science ®Google Scholar
• Dickel H, Bauer A, Brehler R, et al. German S1 guideline: Contact dermatitis. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2022 May;20(5):712–734. doi: 10.1111/ddg.14734
   PubMed Web of Science ®Google Scholar
• Owen JL, Vakharia PP, Silverberg JI. The role and diagnosis of allergic contact dermatitis in patients with atopic dermatitis. Am J Clin Dermatol. 2018 Jun;19(3):293–302. doi: 10.1007/s40257-017-0340-7
   PubMed Web of Science ®Google Scholar
• Johnson H, Novack DE, Adler BL, et al. Can atopic dermatitis and allergic contact dermatitis coexist? Cutis. 2022 Sep;110(3):139–142. doi: 10.12788/cutis.0599
   PubMed Web of Science ®Google Scholar
• Hon KL, Kung JSC, Ng WGG, et al. Emollient treatment of atopic dermatitis: latest evidence and clinical considerations. Drugs Context. 2018;7:212530. doi: 10.7573/dic.212530
   PubMedGoogle Scholar
• Daftary K, Scheman A, Bai H, et al. Rate of patch testing induced anaphylaxis. Dermat Contact Atopic Occup Drug. 2023;34(1):33–35. doi: 10.1089/DERM.0000000000000956
   PubMed Web of Science ®Google Scholar
• Jensen CD, Paulsen E, Andersen KE. Retrospective evaluation of the consequence of alleged patch test sensitization. Contact Dermatitis. 2006;55(1):30–35. doi: 10.1111/j.0105-1873.2006.00863.x
   PubMed Web of Science ®Google Scholar
• Johansen JD, Aalto-Korte K, Agner T, et al. European society of contact dermatitis guideline for diagnostic patch testing – recommendations on best practice. Contact Dermatitis. 2015;73(4):195–221. doi: 10.1111/cod.12432
   PubMed Web of Science ®Google Scholar
• Ophaug S, Schwarzenberger K. Pitfalls in Patch Testing. Dermatol Clin. 2020 Jul;38(3):293–300. doi: 10.1016/j.det.2020.02.007
   PubMed Web of Science ®Google Scholar
• Fowler JF, Maibach HI, Zirwas M, et al. Effects of immunomodulatory agents on patch testing: expert opinion 2012. Dermat Contact Atopic Occup Drug. 2012;23(6):301–303.
   PubMed Web of Science ®Google Scholar
• Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017 Apr;17(4):233–247. doi: 10.1038/nri.2017.1
   PubMed Web of Science ®Google Scholar
• Rosmarin D, Gottlieb AB, Asarch A, et al. Patch-testing while on systemic immunosuppressants. Dermat Contact Atopic Occup Drug. 2009;20(5):265–270. doi: 10.2310/6620.2009.09005
   PubMed Web of Science ®Google Scholar
• Anveden I, Lindberg M, Andersen KE, et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis. 2004 May;50(5):298–303. doi: 10.1111/j.0105-1873.2004.00340.x
   PubMed Web of Science ®Google Scholar
• Patel A, Burns E, Burkemper NM. Methotrexate use in allergic contact dermatitis: a retrospective study: methotrexate use in allergic contact dermatitis. Contact Dermatitis. 2018 Mar;78(3):194–198. doi: 10.1111/cod.12925
   PubMed Web of Science ®Google Scholar
• Roberson F, Luis C, Cruzval-O’Reilly E, et al. Methotrexate and patch testing: a retrospective review. Dermat Contact Atopic Occup Drug. 2022 Aug 1;33(4):264–267.
   PubMed Web of Science ®Google Scholar
• Wentworth AB, Davis MDP. Patch testing with the standard series when receiving immunosuppressive medications. Dermat Contact Atopic Occup Drug. 2014;25(4):195–200. doi: 10.1097/DER.0000000000000048
   PubMed Web of Science ®Google Scholar
• Vena GA, Foti C, Piazzola L, et al. Can cyclosporin a help distinguish allergic from irritant patch test reactions? Contact Dermatitis. 1994 Oct;31(4):256–257. doi: 10.1111/j.1600-0536.1994.tb01998.x
   PubMed Web of Science ®Google Scholar
• Khattri S, Shemer A, Rozenblit M, et al. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. J Allergy Clin Immunol. 2014 Jun 1;133(6):1626–1634. doi: 10.1016/j.jaci.2014.03.003
   PubMed Web of Science ®Google Scholar
• Flori ML, Andreassi L. Patch tests after cyclosporin a treatment in hyperreactive patients. Contact Dermatitis. 1994 Nov;31(5):325. doi: 10.1111/j.1600-0536.1994.tb02031.x
   PubMed Web of Science ®Google Scholar
• Flori L, Perotti R, Mazzatenta C, et al. Cyclosporin a in the treatment of severe allergic contact dermatitis. J Eur Acad Dermatol Venereol. 1993;2(3):200–206. doi: 10.1111/j.1468-3083.1993.tb00036.x
   Google Scholar
• Higgins EM, McLelland J, Friedmann PS, et al. Oral cyclosporin inhibits the expression of contact hypersensitivity in man. J Dermatol Sci. 1991 Mar;2(2):79–83.
   PubMedGoogle Scholar
• Patel AA, Swerlick RA, McCall CO. Azathioprine in dermatology: The past, the present, and the future. J Am Acad Dermatol. 2006 Sep 1;55(3):369–389.
   PubMed Web of Science ®Google Scholar
• Wee JS, White JML, McFadden JP, et al. Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors. Contact Dermatitis. 2010 Mar;62(3):165–169. doi: 10.1111/j.1600-0536.2009.01695.x
   PubMed Web of Science ®Google Scholar
• Verma KK, Bhari N, Sethuraman G. Azathioprine does not influence patch test reactivity in parthenium dermatitis. Contact Dermatitis. 2016 Jan;74(1):64–65. doi: 10.1111/cod.12466
   PubMed Web of Science ®Google Scholar
• Vieyra-Garcia PA, Wolf P. From early immunomodulatory triggers to immunosuppressive outcome: therapeutic implications of the complex interplay between the wavebands of sunlight and the skin. Front Med. 2018 Sep 10;5:232. doi: 10.3389/fmed.2018.00232
   Web of Science ®Google Scholar
• Daunton A, Williams J. The impact of ultraviolet exposure on patch testing in clinical practice: a case-control study. Clin Exp Dermatol. 2020 Jan;45(1):25–29. doi: 10.1111/ced.13987
   PubMed Web of Science ®Google Scholar
• Raffi J, Suresh R, Botto N, et al. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: a retrospective chart review. J Am Acad Dermatol. 2020 Jan;82(1):132–138.
   PubMed Web of Science ®Google Scholar
• de Wijs LEM, van der Waa JD, Nijsten T, et al. Effects of dupilumab treatment on patch test reactions: A retrospective evaluation. Clin Exp Allergy. 2021 Jul;51(7):959–967. doi: 10.1111/cea.13892
   PubMed Web of Science ®Google Scholar
• Jo CE, Mufti A, Sachdeva M, et al. Effect of dupilumab on allergic contact dermatitis and patch testing. J Am Acad Dermatol. 2021 Jun;84(6):1772–1776.
   PubMed Web of Science ®Google Scholar
• Bocquel S, Soria A, Raison-Peyron N, et al. Impact of dupilumab on patch-test results and allergic contact dermatitis: a prospective multicenter study. J Am Acad Dermatol [Internet]. 2023 Oct 21; [cited 2023 Nov 8]. Available from: https://www.jaad.org/article/S0190-9622(23)03032-3/fulltext
   PubMedGoogle Scholar
• Mainville L, Veillette H, Houle MC. Sequential patch testing in a patient treated with dupilumab then with upadacitinib: differences in patch test results as well as in disease control. Contact Dermatitis. 2023 May;88(5):402–404. doi: 10.1111/cod.14278
   PubMed Web of Science ®Google Scholar
• Traidl S, Freimooser S, Werfel T. Janus kinase inhibitors for the therapy of atopic dermatitis. Allergol Sel. 2021 Aug 27;5(1):293–304.
   PubMedGoogle Scholar
• Kim N, Notik S, Gottlieb AB, et al. Patch test results in psoriasis patients on biologics. Dermat Contact Atopic Occup Drug. 2014;25(4):182–190. doi: 10.1097/DER.0000000000000056
   PubMed Web of Science ®Google Scholar
• Lazzarini R, Kawakami NT, Suzuki N, et al. Patch tests in patients using immunosuppressants and/or cytokine inhibitors: descriptive analysis of 16 cases. An Bras Dermatol. 2023;98(1):99–101. doi: 10.1016/j.abd.2022.03.005
   PubMed Web of Science ®Google Scholar